Blood Glucose Monitoring System (BGMS) Market 2025: Advancing Diabetes Care with Innovation and Accessibility
The Blood Glucose Monitoring System (BGMS) market is at the forefront of diabetes management, offering critical tools that enable millions of individuals worldwide to monitor and control their blood sugar levels effectively. As diabetes prevalence continues to rise globally, the demand for accurate, convenient, and affordable blood glucose monitoring devices is accelerating. The market landscape in 2025 is defined by technological breakthroughs, expanding healthcare infrastructure, and increasing patient awareness. This comprehensive overview examines the core market drivers, technological innovations, regional dynamics, and strategic priorities shaping the future of the BGMS industry.
Key Market Drivers
Several influential factors are propelling growth in the BGMS market.
- Rising Diabetes Prevalence: The global increase in both Type 1 and Type 2 diabetes is a primary driver. Changing lifestyles, urbanization, and aging populations contribute to the surge, heightening the need for regular glucose monitoring to prevent complications.
- Shift Toward Patient Empowerment: Modern healthcare increasingly emphasizes patient self-management. BGMS devices empower individuals to track their glucose levels independently, promoting proactive disease control and reducing hospital visits.
- Technological Advancements: Innovations making BGMS devices more accurate, user-friendly, and less invasive encourage frequent use. Portable devices with faster response times and smaller blood sample requirements are transforming patient experiences.
- Healthcare Infrastructure and Reimbursement: Expanded healthcare coverage and government initiatives supporting chronic disease management improve access to BGMS devices, especially in developing regions.
- Growing Awareness and Education: Campaigns highlighting the importance of glycemic control are educating both patients and clinicians, increasing routine blood glucose testing.
Innovation Driving Market Evolution
Innovation is the lifeblood of the BGMS market, leading to enhanced patient outcomes and broader adoption.
- Continuous Glucose Monitoring (CGM): CGM technology is revolutionizing glucose management by providing real-time, continuous data through wearable sensors. This shift from intermittent testing to constant monitoring enables better glycemic control and timely interventions.
- Non-Invasive Monitoring: Emerging technologies aim to eliminate the need for finger-pricks through optical sensors and transdermal methods, reducing pain and improving user compliance.
- Digital Integration and Connectivity: BGMS devices now seamlessly connect to smartphones and cloud platforms, allowing users to track trends, receive personalized alerts, and share data with healthcare providers for remote management.
- Artificial Intelligence and Predictive Analytics: AI-powered BGMS platforms analyze glucose patterns to forecast fluctuations, offering personalized insights that help prevent hypoglycemic or hyperglycemic events.
- Improved Sensor Longevity: Advances in sensor durability and battery efficiency extend device lifespan, reducing maintenance and operational costs for users.
Regional Market Dynamics
Understanding regional nuances is critical for strategic growth in the BGMS market.
- North America: Leading the market, North America benefits from advanced healthcare infrastructure, widespread insurance coverage, and early adoption of cutting-edge technologies. A high diabetes burden and strong regulatory support further stimulate growth.
- Europe: Europe maintains significant market share with robust healthcare systems, reimbursement models, and growing patient awareness. Countries across Western and Northern Europe are embracing CGM and telehealth solutions.
- Asia-Pacific: This region is experiencing the fastest growth due to a rapidly rising diabetic population, increasing healthcare spending, and government initiatives focused on chronic disease management. Key markets like China, India, and Japan are pivotal drivers.
- Latin America, Middle East, and Africa: Though still developing, these regions show promise as improving healthcare infrastructure and rising health consciousness drive BGMS adoption. Partnerships and affordability remain key considerations.
Strategic Considerations for Market Success
To capitalize on the expanding BGMS market, companies should focus on several strategic elements:
- User-Centric Device Design: Creating devices that prioritize simplicity, portability, and minimal invasiveness caters to a broad demographic, including elderly and technologically inexperienced users.
- Holistic Diabetes Management Solutions: Integrating BGMS devices with apps, data analytics, and healthcare provider networks enhances patient engagement and improves outcomes.
- Regulatory and Quality Compliance: Ensuring adherence to stringent safety and efficacy standards builds clinician and patient confidence, expediting market approvals.
- Tailored Regional Strategies: Adapting marketing, pricing, and distribution to align with local healthcare policies, economic conditions, and cultural preferences optimizes market penetration.
- Collaborations and Partnerships: Collaborating with healthcare providers, insurers, and technology firms fosters innovation, improves market access, and supports comprehensive patient care.
- Patient Education and Support Programs: Investing in educational initiatives encourages adherence to glucose monitoring regimens, increasing device utilization and loyalty.
Conclusion
The Blood Glucose Monitoring System market 2025 is poised for remarkable growth driven by technological innovation, rising diabetes prevalence, and a global shift toward personalized healthcare. Continuous advancements in CGM, non-invasive monitoring, and AI integration are transforming how patients manage their glucose levels, offering improved accuracy, convenience, and engagement. Regional growth disparities underscore the importance of customized strategies to maximize reach and impact. By focusing on user-friendly design, regulatory compliance, and strategic partnerships, market players can unlock significant opportunities and contribute to better health outcomes worldwide. As diabetes care evolves, BGMS devices will remain indispensable tools in managing this chronic condition with greater precision and compassion.
NOTE:
Quants and Trends is proud to offer an extensive portfolio of meticulously researched healthcare market reports, numbering in the thousands. We also provide tailored customization services to ensure our insights align precisely with your strategic objectives and informational needs. For personalized assistance or to discuss your specific requirements, we invite you to get in touch with our team. We also encourage you to request a complimentary sample PDF report. Please visit our Sample Request Page to receive yours today.
Key Market Players
Roche
LifeScan
Abbott
Ascensia
ARKRAY
I-SENS
Omron
B. Braun
77 Elektronika
AgaMatrix
ALL Medicus
Terumo
Sinocare
Yicheng
Yuwell
Acon
Segmentation By Type
Blood Glucose Test Strips
Blood Glucose Meter
Segmentation By Application
Hospital
Household
Segmentation By Region
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the BGMS Market 2025?
The growing prevalence of diabetes globally, along with increasing health awareness, fuels the demand for efficient BGMS. Advancements in technology, such as non-invasive and continuous glucose monitoring devices, are enhancing patient compliance and providing more accurate results.
What are the weaknesses of the BGMS Market 2025?
The high cost of advanced BGMS devices, especially continuous glucose monitoring systems, limits their accessibility for many diabetic patients. Additionally, some devices require frequent calibration, which may be inconvenient for users.
What are the opportunities in the BGMS Market 2025?
There is a significant opportunity in expanding the BGMS market in emerging economies where the prevalence of diabetes is rising. Advancements in wearable technology and smartphone integration could open up new avenues for seamless monitoring and data management.
What are the threats to the BGMS Market 2025?
The market faces threats from competition with alternative monitoring methods, such as urine testing kits and home blood tests, which are perceived as more affordable. Additionally, regulatory challenges and pricing pressure may affect market growth.
Market PESTEL Analysis
What are the political factors affecting the BGMS Market 2025?
Government regulations and healthcare policies play a significant role in the BGMS market. Policies that support diabetes management and medical device approvals can drive market growth. On the other hand, stringent regulations and approval processes may delay product launches.
What are the economic factors affecting the BGMS Market 2025?
The affordability of BGMS devices is a key economic factor. Economic conditions, such as income levels and healthcare spending, influence patient access to advanced monitoring systems. The cost of devices, particularly in emerging markets, can be a barrier to widespread adoption.
What are the social factors affecting the BGMS Market 2025?
Social awareness about diabetes management is increasing, with more people focusing on health and wellness. This shift towards preventive healthcare creates a demand for reliable and easy-to-use BGMS. However, there may be resistance to adopting new technologies, especially among older populations.
What are the technological factors affecting the BGMS Market 2025?
Technological advancements in sensor technology, non-invasive glucose monitoring, and mobile integration are transforming the BGMS market. These innovations improve accuracy, convenience, and real-time data management, making it easier for users to manage their condition effectively.
What are the environmental factors affecting the BGMS Market 2025?
Environmental factors include the sustainability of manufacturing processes for BGMS devices and the disposal of related medical waste. Companies are increasingly focusing on eco-friendly production methods and reducing the environmental impact of packaging and electronics.
What are the legal factors affecting the BGMS Market 2025?
Legal factors involve compliance with medical device regulations and data protection laws. With BGMS devices collecting sensitive health data, adhering to privacy regulations, such as GDPR or HIPAA, is crucial. Furthermore, intellectual property rights and patent issues may also impact market competition.
Market SIPOC Analysis
What are the suppliers in the BGMS Market 2025?
Suppliers in the BGMS market include manufacturers of sensors, glucose test strips, and other components essential for the production of monitoring systems. Additionally, technology companies that provide software and mobile integration platforms are key suppliers.
What are the inputs in the BGMS Market 2025?
The inputs consist of raw materials like electronics, sensors, and consumables such as test strips and lancets. Research and development efforts to enhance device functionality and user experience also contribute as critical inputs.
What are the processes in the BGMS Market 2025?
The processes involve the design, manufacturing, and assembly of BGMS devices, followed by rigorous testing and quality control. Marketing and distribution strategies are also essential processes to ensure the devices reach the target market.
What are the outputs in the BGMS Market 2025?
The outputs are the final BGMS products, including various types of glucose meters, continuous glucose monitoring systems, and related consumables. These products are delivered to hospitals, clinics, pharmacies, and directly to consumers.
What are the customers in the BGMS Market 2025?
Customers include diabetic patients, healthcare providers such as hospitals and clinics, as well as distributors and retailers who sell the devices to end users. Additionally, healthcare institutions and research organizations also form part of the customer base.
Market Porter's Five Forces
What is the threat of new entrants in the BGMS Market 2025?
The threat of new entrants is moderate. While the market offers growth opportunities, the high capital investment, stringent regulatory requirements, and the need for specialized technology make it difficult for new companies to enter and compete with established players.
What is the bargaining power of suppliers in the BGMS Market 2025?
The bargaining power of suppliers is moderate. While there are several suppliers for components like sensors and test strips, key suppliers with advanced technology or unique products can influence pricing and product availability, particularly in the high-tech segment.
What is the bargaining power of buyers in the BGMS Market 2025?
The bargaining power of buyers is high, especially for healthcare providers and diabetic patients who have access to a range of monitoring devices. With the growing availability of alternatives and increasing competition, buyers can demand better quality, lower prices, and more advanced features.
What is the threat of substitute products in the BGMS Market 2025?
The threat of substitutes is moderate. While BGMS devices are the primary option for monitoring blood glucose, alternative methods such as urine tests or the development of non-invasive technologies may serve as potential substitutes, albeit with limitations in accuracy or convenience.
What is the intensity of competitive rivalry in the BGMS Market 2025?
The intensity of competitive rivalry is high. The market is crowded with well-established players and new entrants offering diverse products with varying features and price points. Innovation, pricing strategies, and regulatory compliance are key factors in maintaining competitiveness in this dynamic market.
Market Upstream Analysis
What are the key upstream factors in the BGMS Market 2025?
The key upstream factors include the availability and cost of raw materials for sensors, electronics, and consumables such as test strips and lancets. Additionally, advancements in technology and research and development efforts play a critical role in improving device functionality and accuracy.
How does research and development impact the BGMS Market 2025?
Research and development are vital upstream activities that influence innovation in BGMS devices. Continuous improvements in sensor technology, non-invasive monitoring methods, and data integration with mobile platforms are critical to meeting consumer demands and improving the overall market offering.
What role do suppliers play in the BGMS Market 2025?
Suppliers of raw materials, sensors, test strips, and advanced technology components are crucial upstream players. Their ability to deliver high-quality components on time and at competitive prices directly impacts the production and cost structure of BGMS devices.
How do regulatory bodies influence the BGMS Market 2025?
Regulatory bodies, such as the FDA and CE, are key upstream factors, as they define the standards for device approval and market entry. Compliance with these regulations ensures the safety, efficacy, and quality of BGMS devices, which can influence market entry timelines and costs for manufacturers.
What challenges exist in the upstream segment of the BGMS Market 2025?
Challenges include the high cost and availability of specialized materials required for BGMS production. Additionally, keeping up with stringent regulations and the rapid pace of technological advancements poses ongoing challenges for suppliers and manufacturers in the upstream segment.
Market Midstream Analysis
What are the key midstream activities in the BGMS Market 2025?
The key midstream activities include the manufacturing, assembly, and testing of BGMS devices. This stage focuses on integrating components such as sensors, displays, and software to create functional and reliable blood glucose monitoring systems.
How does technology integration impact the midstream segment of the BGMS Market 2025?
Technology integration is crucial in the midstream segment. The seamless incorporation of mobile apps, cloud-based data storage, and real-time monitoring features into BGMS devices enhances their appeal and usability, allowing for a more comprehensive user experience.
What are the challenges faced by manufacturers in the BGMS Market 2025?
Manufacturers face challenges such as maintaining high-quality standards, meeting regulatory compliance, and managing supply chain disruptions. Additionally, the complexity of integrating advanced technology while keeping production costs low presents a constant challenge.
How do distribution channels influence the midstream segment of the BGMS Market 2025?
Distribution channels are vital for ensuring the timely delivery of BGMS devices to healthcare providers, pharmacies, and directly to consumers. The efficiency of these channels impacts product availability and customer satisfaction, especially in regions with high demand.
What role does quality control play in the midstream segment of the BGMS Market 2025?
Quality control is essential to ensure that BGMS devices meet the required standards of accuracy and reliability. Consistent testing and inspection during the manufacturing process help avoid defects, minimize recalls, and maintain brand reputation in the competitive market.
Market Downstream Analysis
What are the key downstream activities in the BGMS Market 2025?
Key downstream activities include the distribution and retail of BGMS devices, along with post-purchase customer support and education. This stage focuses on ensuring that devices reach end users through various retail, pharmacy, and healthcare channels.
How do healthcare providers impact the downstream segment of the BGMS Market 2025?
Healthcare providers play a critical role by recommending and prescribing BGMS devices to diabetic patients. Their ability to educate patients on proper usage and integrate monitoring devices into treatment plans influences patient compliance and overall market demand.
What role does customer support and service play in the BGMS Market 2025?
Customer support and service are essential for maintaining customer satisfaction and loyalty. Offering troubleshooting, guidance on device usage, and providing technical support ensures that patients and healthcare professionals continue to use BGMS devices effectively.
How do market trends and consumer behavior affect the downstream segment of the BGMS Market 2025?
Consumer behavior, especially in terms of increasing awareness about health and diabetes management, drives the demand for BGMS devices. Market trends, such as the rise in demand for non-invasive and connected devices, shape the downstream strategies of retailers and healthcare providers.
What challenges exist in the downstream segment of the BGMS Market 2025?
Challenges in the downstream segment include reaching underserved populations in emerging markets, addressing pricing barriers, and ensuring consistent product availability. Additionally, the complexity of educating patients on new technologies and maintaining post-purchase support can also be demanding.
Chapter 1, to describe BGMS (Blood Glucose Monitoring System) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of BGMS (Blood Glucose Monitoring System), with price, sales, revenue and global market share of BGMS (Blood Glucose Monitoring System) from 2018 to 2023.
Chapter 3, the BGMS (Blood Glucose Monitoring System) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the BGMS (Blood Glucose Monitoring System) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and BGMS (Blood Glucose Monitoring System) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of BGMS (Blood Glucose Monitoring System).
Chapter 14 and 15, to describe BGMS (Blood Glucose Monitoring System) sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of BGMS (Blood Glucose Monitoring System)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global BGMS (Blood Glucose Monitoring System) Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Blood Glucose Test Strips
1.3.3 Blood Glucose Meter
1.4 Market Analysis by Application
1.4.1 Overview: Global BGMS (Blood Glucose Monitoring System) Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Household
1.5 Global BGMS (Blood Glucose Monitoring System) Market Size & Forecast
1.5.1 Global BGMS (Blood Glucose Monitoring System) Consumption Value (2018 & 2022 & 2029)
1.5.2 Global BGMS (Blood Glucose Monitoring System) Sales Quantity (2018-2029)
1.5.3 Global BGMS (Blood Glucose Monitoring System) Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche BGMS (Blood Glucose Monitoring System) Product and Services
2.1.4 Roche BGMS (Blood Glucose Monitoring System) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Recent Developments/Updates
2.2 LifeScan
2.2.1 LifeScan Details
2.2.2 LifeScan Major Business
2.2.3 LifeScan BGMS (Blood Glucose Monitoring System) Product and Services
2.2.4 LifeScan BGMS (Blood Glucose Monitoring System) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 LifeScan Recent Developments/Updates
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott BGMS (Blood Glucose Monitoring System) Product and Services
2.3.4 Abbott BGMS (Blood Glucose Monitoring System) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Abbott Recent Developments/Updates
2.4 Ascensia
2.4.1 Ascensia Details
2.4.2 Ascensia Major Business
2.4.3 Ascensia BGMS (Blood Glucose Monitoring System) Product and Services
2.4.4 Ascensia BGMS (Blood Glucose Monitoring System) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Ascensia Recent Developments/Updates
2.5 ARKRAY
2.5.1 ARKRAY Details
2.5.2 ARKRAY Major Business
2.5.3 ARKRAY BGMS (Blood Glucose Monitoring System) Product and Services
2.5.4 ARKRAY BGMS (Blood Glucose Monitoring System) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 ARKRAY Recent Developments/Updates
2.6 I-SENS
2.6.1 I-SENS Details
2.6.2 I-SENS Major Business
2.6.3 I-SENS BGMS (Blood Glucose Monitoring System) Product and Services
2.6.4 I-SENS BGMS (Blood Glucose Monitoring System) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 I-SENS Recent Developments/Updates
2.7 Omron
2.7.1 Omron Details
2.7.2 Omron Major Business
2.7.3 Omron BGMS (Blood Glucose Monitoring System) Product and Services
2.7.4 Omron BGMS (Blood Glucose Monitoring System) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Omron Recent Developments/Updates
2.8 B. Braun
2.8.1 B. Braun Details
2.8.2 B. Braun Major Business
2.8.3 B. Braun BGMS (Blood Glucose Monitoring System) Product and Services
2.8.4 B. Braun BGMS (Blood Glucose Monitoring System) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 B. Braun Recent Developments/Updates
2.9 77 Elektronika
2.9.1 77 Elektronika Details
2.9.2 77 Elektronika Major Business
2.9.3 77 Elektronika BGMS (Blood Glucose Monitoring System) Product and Services
2.9.4 77 Elektronika BGMS (Blood Glucose Monitoring System) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 77 Elektronika Recent Developments/Updates
2.10 AgaMatrix
2.10.1 AgaMatrix Details
2.10.2 AgaMatrix Major Business
2.10.3 AgaMatrix BGMS (Blood Glucose Monitoring System) Product and Services
2.10.4 AgaMatrix BGMS (Blood Glucose Monitoring System) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 AgaMatrix Recent Developments/Updates
2.11 ALL Medicus
2.11.1 ALL Medicus Details
2.11.2 ALL Medicus Major Business
2.11.3 ALL Medicus BGMS (Blood Glucose Monitoring System) Product and Services
2.11.4 ALL Medicus BGMS (Blood Glucose Monitoring System) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 ALL Medicus Recent Developments/Updates
2.12 Terumo
2.12.1 Terumo Details
2.12.2 Terumo Major Business
2.12.3 Terumo BGMS (Blood Glucose Monitoring System) Product and Services
2.12.4 Terumo BGMS (Blood Glucose Monitoring System) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Terumo Recent Developments/Updates
2.13 Sinocare
2.13.1 Sinocare Details
2.13.2 Sinocare Major Business
2.13.3 Sinocare BGMS (Blood Glucose Monitoring System) Product and Services
2.13.4 Sinocare BGMS (Blood Glucose Monitoring System) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Sinocare Recent Developments/Updates
2.14 Yicheng
2.14.1 Yicheng Details
2.14.2 Yicheng Major Business
2.14.3 Yicheng BGMS (Blood Glucose Monitoring System) Product and Services
2.14.4 Yicheng BGMS (Blood Glucose Monitoring System) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Yicheng Recent Developments/Updates
2.15 Yuwell
2.15.1 Yuwell Details
2.15.2 Yuwell Major Business
2.15.3 Yuwell BGMS (Blood Glucose Monitoring System) Product and Services
2.15.4 Yuwell BGMS (Blood Glucose Monitoring System) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Yuwell Recent Developments/Updates
2.16 Acon
2.16.1 Acon Details
2.16.2 Acon Major Business
2.16.3 Acon BGMS (Blood Glucose Monitoring System) Product and Services
2.16.4 Acon BGMS (Blood Glucose Monitoring System) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Acon Recent Developments/Updates
3 Competitive Environment: BGMS (Blood Glucose Monitoring System) by Manufacturer
3.1 Global BGMS (Blood Glucose Monitoring System) Sales Quantity by Manufacturer (2018-2023)
3.2 Global BGMS (Blood Glucose Monitoring System) Revenue by Manufacturer (2018-2023)
3.3 Global BGMS (Blood Glucose Monitoring System) Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of BGMS (Blood Glucose Monitoring System) by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 BGMS (Blood Glucose Monitoring System) Manufacturer Market Share in 2022
3.4.2 Top 6 BGMS (Blood Glucose Monitoring System) Manufacturer Market Share in 2022
3.5 BGMS (Blood Glucose Monitoring System) Market: Overall Company Footprint Analysis
3.5.1 BGMS (Blood Glucose Monitoring System) Market: Region Footprint
3.5.2 BGMS (Blood Glucose Monitoring System) Market: Company Product Type Footprint
3.5.3 BGMS (Blood Glucose Monitoring System) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global BGMS (Blood Glucose Monitoring System) Market Size by Region
4.1.1 Global BGMS (Blood Glucose Monitoring System) Sales Quantity by Region (2018-2029)
4.1.2 Global BGMS (Blood Glucose Monitoring System) Consumption Value by Region (2018-2029)
4.1.3 Global BGMS (Blood Glucose Monitoring System) Average Price by Region (2018-2029)
4.2 North America BGMS (Blood Glucose Monitoring System) Consumption Value (2018-2029)
4.3 Europe BGMS (Blood Glucose Monitoring System) Consumption Value (2018-2029)
4.4 Asia-Pacific BGMS (Blood Glucose Monitoring System) Consumption Value (2018-2029)
4.5 South America BGMS (Blood Glucose Monitoring System) Consumption Value (2018-2029)
4.6 Middle East and Africa BGMS (Blood Glucose Monitoring System) Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global BGMS (Blood Glucose Monitoring System) Sales Quantity by Type (2018-2029)
5.2 Global BGMS (Blood Glucose Monitoring System) Consumption Value by Type (2018-2029)
5.3 Global BGMS (Blood Glucose Monitoring System) Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global BGMS (Blood Glucose Monitoring System) Sales Quantity by Application (2018-2029)
6.2 Global BGMS (Blood Glucose Monitoring System) Consumption Value by Application (2018-2029)
6.3 Global BGMS (Blood Glucose Monitoring System) Average Price by Application (2018-2029)
7 North America
7.1 North America BGMS (Blood Glucose Monitoring System) Sales Quantity by Type (2018-2029)
7.2 North America BGMS (Blood Glucose Monitoring System) Sales Quantity by Application (2018-2029)
7.3 North America BGMS (Blood Glucose Monitoring System) Market Size by Country
7.3.1 North America BGMS (Blood Glucose Monitoring System) Sales Quantity by Country (2018-2029)
7.3.2 North America BGMS (Blood Glucose Monitoring System) Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe BGMS (Blood Glucose Monitoring System) Sales Quantity by Type (2018-2029)
8.2 Europe BGMS (Blood Glucose Monitoring System) Sales Quantity by Application (2018-2029)
8.3 Europe BGMS (Blood Glucose Monitoring System) Market Size by Country
8.3.1 Europe BGMS (Blood Glucose Monitoring System) Sales Quantity by Country (2018-2029)
8.3.2 Europe BGMS (Blood Glucose Monitoring System) Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific BGMS (Blood Glucose Monitoring System) Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific BGMS (Blood Glucose Monitoring System) Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific BGMS (Blood Glucose Monitoring System) Market Size by Region
9.3.1 Asia-Pacific BGMS (Blood Glucose Monitoring System) Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific BGMS (Blood Glucose Monitoring System) Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America BGMS (Blood Glucose Monitoring System) Sales Quantity by Type (2018-2029)
10.2 South America BGMS (Blood Glucose Monitoring System) Sales Quantity by Application (2018-2029)
10.3 South America BGMS (Blood Glucose Monitoring System) Market Size by Country
10.3.1 South America BGMS (Blood Glucose Monitoring System) Sales Quantity by Country (2018-2029)
10.3.2 South America BGMS (Blood Glucose Monitoring System) Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa BGMS (Blood Glucose Monitoring System) Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa BGMS (Blood Glucose Monitoring System) Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa BGMS (Blood Glucose Monitoring System) Market Size by Country
11.3.1 Middle East & Africa BGMS (Blood Glucose Monitoring System) Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa BGMS (Blood Glucose Monitoring System) Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 BGMS (Blood Glucose Monitoring System) Market Drivers
12.2 BGMS (Blood Glucose Monitoring System) Market Restraints
12.3 BGMS (Blood Glucose Monitoring System) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of BGMS (Blood Glucose Monitoring System) and Key Manufacturers
13.2 Manufacturing Costs Percentage of BGMS (Blood Glucose Monitoring System)
13.3 BGMS (Blood Glucose Monitoring System) Production Process
13.4 BGMS (Blood Glucose Monitoring System) Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 BGMS (Blood Glucose Monitoring System) Typical Distributors
14.3 BGMS (Blood Glucose Monitoring System) Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global BGMS (Blood Glucose Monitoring System) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global BGMS (Blood Glucose Monitoring System) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche BGMS (Blood Glucose Monitoring System) Product and Services
Table 6. Roche BGMS (Blood Glucose Monitoring System) Sales Quantity (M Units), Average Price (USD/K Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Roche Recent Developments/Updates
Table 8. LifeScan Basic Information, Manufacturing Base and Competitors
Table 9. LifeScan Major Business
Table 10. LifeScan BGMS (Blood Glucose Monitoring System) Product and Services
Table 11. LifeScan BGMS (Blood Glucose Monitoring System) Sales Quantity (M Units), Average Price (USD/K Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. LifeScan Recent Developments/Updates
Table 13. Abbott Basic Information, Manufacturing Base and Competitors
Table 14. Abbott Major Business
Table 15. Abbott BGMS (Blood Glucose Monitoring System) Product and Services
Table 16. Abbott BGMS (Blood Glucose Monitoring System) Sales Quantity (M Units), Average Price (USD/K Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Abbott Recent Developments/Updates
Table 18. Ascensia Basic Information, Manufacturing Base and Competitors
Table 19. Ascensia Major Business
Table 20. Ascensia BGMS (Blood Glucose Monitoring System) Product and Services
Table 21. Ascensia BGMS (Blood Glucose Monitoring System) Sales Quantity (M Units), Average Price (USD/K Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Ascensia Recent Developments/Updates
Table 23. ARKRAY Basic Information, Manufacturing Base and Competitors
Table 24. ARKRAY Major Business
Table 25. ARKRAY BGMS (Blood Glucose Monitoring System) Product and Services
Table 26. ARKRAY BGMS (Blood Glucose Monitoring System) Sales Quantity (M Units), Average Price (USD/K Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. ARKRAY Recent Developments/Updates
Table 28. I-SENS Basic Information, Manufacturing Base and Competitors
Table 29. I-SENS Major Business
Table 30. I-SENS BGMS (Blood Glucose Monitoring System) Product and Services
Table 31. I-SENS BGMS (Blood Glucose Monitoring System) Sales Quantity (M Units), Average Price (USD/K Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. I-SENS Recent Developments/Updates
Table 33. Omron Basic Information, Manufacturing Base and Competitors
Table 34. Omron Major Business
Table 35. Omron BGMS (Blood Glucose Monitoring System) Product and Services
Table 36. Omron BGMS (Blood Glucose Monitoring System) Sales Quantity (M Units), Average Price (USD/K Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Omron Recent Developments/Updates
Table 38. B. Braun Basic Information, Manufacturing Base and Competitors
Table 39. B. Braun Major Business
Table 40. B. Braun BGMS (Blood Glucose Monitoring System) Product and Services
Table 41. B. Braun BGMS (Blood Glucose Monitoring System) Sales Quantity (M Units), Average Price (USD/K Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. B. Braun Recent Developments/Updates
Table 43. 77 Elektronika Basic Information, Manufacturing Base and Competitors
Table 44. 77 Elektronika Major Business
Table 45. 77 Elektronika BGMS (Blood Glucose Monitoring System) Product and Services
Table 46. 77 Elektronika BGMS (Blood Glucose Monitoring System) Sales Quantity (M Units), Average Price (USD/K Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. 77 Elektronika Recent Developments/Updates
Table 48. AgaMatrix Basic Information, Manufacturing Base and Competitors
Table 49. AgaMatrix Major Business
Table 50. AgaMatrix BGMS (Blood Glucose Monitoring System) Product and Services
Table 51. AgaMatrix BGMS (Blood Glucose Monitoring System) Sales Quantity (M Units), Average Price (USD/K Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. AgaMatrix Recent Developments/Updates
Table 53. ALL Medicus Basic Information, Manufacturing Base and Competitors
Table 54. ALL Medicus Major Business
Table 55. ALL Medicus BGMS (Blood Glucose Monitoring System) Product and Services
Table 56. ALL Medicus BGMS (Blood Glucose Monitoring System) Sales Quantity (M Units), Average Price (USD/K Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. ALL Medicus Recent Developments/Updates
Table 58. Terumo Basic Information, Manufacturing Base and Competitors
Table 59. Terumo Major Business
Table 60. Terumo BGMS (Blood Glucose Monitoring System) Product and Services
Table 61. Terumo BGMS (Blood Glucose Monitoring System) Sales Quantity (M Units), Average Price (USD/K Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Terumo Recent Developments/Updates
Table 63. Sinocare Basic Information, Manufacturing Base and Competitors
Table 64. Sinocare Major Business
Table 65. Sinocare BGMS (Blood Glucose Monitoring System) Product and Services
Table 66. Sinocare BGMS (Blood Glucose Monitoring System) Sales Quantity (M Units), Average Price (USD/K Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Sinocare Recent Developments/Updates
Table 68. Yicheng Basic Information, Manufacturing Base and Competitors
Table 69. Yicheng Major Business
Table 70. Yicheng BGMS (Blood Glucose Monitoring System) Product and Services
Table 71. Yicheng BGMS (Blood Glucose Monitoring System) Sales Quantity (M Units), Average Price (USD/K Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Yicheng Recent Developments/Updates
Table 73. Yuwell Basic Information, Manufacturing Base and Competitors
Table 74. Yuwell Major Business
Table 75. Yuwell BGMS (Blood Glucose Monitoring System) Product and Services
Table 76. Yuwell BGMS (Blood Glucose Monitoring System) Sales Quantity (M Units), Average Price (USD/K Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Yuwell Recent Developments/Updates
Table 78. Acon Basic Information, Manufacturing Base and Competitors
Table 79. Acon Major Business
Table 80. Acon BGMS (Blood Glucose Monitoring System) Product and Services
Table 81. Acon BGMS (Blood Glucose Monitoring System) Sales Quantity (M Units), Average Price (USD/K Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Acon Recent Developments/Updates
Table 83. Global BGMS (Blood Glucose Monitoring System) Sales Quantity by Manufacturer (2018-2023) & (M Units)
Table 84. Global BGMS (Blood Glucose Monitoring System) Revenue by Manufacturer (2018-2023) & (USD Million)
Table 85. Global BGMS (Blood Glucose Monitoring System) Average Price by Manufacturer (2018-2023) & (USD/K Unit)
Table 86. Market Position of Manufacturers in BGMS (Blood Glucose Monitoring System), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 87. Head Office and BGMS (Blood Glucose Monitoring System) Production Site of Key Manufacturer
Table 88. BGMS (Blood Glucose Monitoring System) Market: Company Product Type Footprint
Table 89. BGMS (Blood Glucose Monitoring System) Market: Company Product Application Footprint
Table 90. BGMS (Blood Glucose Monitoring System) New Market Entrants and Barriers to Market Entry
Table 91. BGMS (Blood Glucose Monitoring System) Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global BGMS (Blood Glucose Monitoring System) Sales Quantity by Region (2018-2023) & (M Units)
Table 93. Global BGMS (Blood Glucose Monitoring System) Sales Quantity by Region (2024-2029) & (M Units)
Table 94. Global BGMS (Blood Glucose Monitoring System) Consumption Value by Region (2018-2023) & (USD Million)
Table 95. Global BGMS (Blood Glucose Monitoring System) Consumption Value by Region (2024-2029) & (USD Million)
Table 96. Global BGMS (Blood Glucose Monitoring System) Average Price by Region (2018-2023) & (USD/K Unit)
Table 97. Global BGMS (Blood Glucose Monitoring System) Average Price by Region (2024-2029) & (USD/K Unit)
Table 98. Global BGMS (Blood Glucose Monitoring System) Sales Quantity by Type (2018-2023) & (M Units)
Table 99. Global BGMS (Blood Glucose Monitoring System) Sales Quantity by Type (2024-2029) & (M Units)
Table 100. Global BGMS (Blood Glucose Monitoring System) Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Global BGMS (Blood Glucose Monitoring System) Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Global BGMS (Blood Glucose Monitoring System) Average Price by Type (2018-2023) & (USD/K Unit)
Table 103. Global BGMS (Blood Glucose Monitoring System) Average Price by Type (2024-2029) & (USD/K Unit)
Table 104. Global BGMS (Blood Glucose Monitoring System) Sales Quantity by Application (2018-2023) & (M Units)
Table 105. Global BGMS (Blood Glucose Monitoring System) Sales Quantity by Application (2024-2029) & (M Units)
Table 106. Global BGMS (Blood Glucose Monitoring System) Consumption Value by Application (2018-2023) & (USD Million)
Table 107. Global BGMS (Blood Glucose Monitoring System) Consumption Value by Application (2024-2029) & (USD Million)
Table 108. Global BGMS (Blood Glucose Monitoring System) Average Price by Application (2018-2023) & (USD/K Unit)
Table 109. Global BGMS (Blood Glucose Monitoring System) Average Price by Application (2024-2029) & (USD/K Unit)
Table 110. North America BGMS (Blood Glucose Monitoring System) Sales Quantity by Type (2018-2023) & (M Units)
Table 111. North America BGMS (Blood Glucose Monitoring System) Sales Quantity by Type (2024-2029) & (M Units)
Table 112. North America BGMS (Blood Glucose Monitoring System) Sales Quantity by Application (2018-2023) & (M Units)
Table 113. North America BGMS (Blood Glucose Monitoring System) Sales Quantity by Application (2024-2029) & (M Units)
Table 114. North America BGMS (Blood Glucose Monitoring System) Sales Quantity by Country (2018-2023) & (M Units)
Table 115. North America BGMS (Blood Glucose Monitoring System) Sales Quantity by Country (2024-2029) & (M Units)
Table 116. North America BGMS (Blood Glucose Monitoring System) Consumption Value by Country (2018-2023) & (USD Million)
Table 117. North America BGMS (Blood Glucose Monitoring System) Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Europe BGMS (Blood Glucose Monitoring System) Sales Quantity by Type (2018-2023) & (M Units)
Table 119. Europe BGMS (Blood Glucose Monitoring System) Sales Quantity by Type (2024-2029) & (M Units)
Table 120. Europe BGMS (Blood Glucose Monitoring System) Sales Quantity by Application (2018-2023) & (M Units)
Table 121. Europe BGMS (Blood Glucose Monitoring System) Sales Quantity by Application (2024-2029) & (M Units)
Table 122. Europe BGMS (Blood Glucose Monitoring System) Sales Quantity by Country (2018-2023) & (M Units)
Table 123. Europe BGMS (Blood Glucose Monitoring System) Sales Quantity by Country (2024-2029) & (M Units)
Table 124. Europe BGMS (Blood Glucose Monitoring System) Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe BGMS (Blood Glucose Monitoring System) Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific BGMS (Blood Glucose Monitoring System) Sales Quantity by Type (2018-2023) & (M Units)
Table 127. Asia-Pacific BGMS (Blood Glucose Monitoring System) Sales Quantity by Type (2024-2029) & (M Units)
Table 128. Asia-Pacific BGMS (Blood Glucose Monitoring System) Sales Quantity by Application (2018-2023) & (M Units)
Table 129. Asia-Pacific BGMS (Blood Glucose Monitoring System) Sales Quantity by Application (2024-2029) & (M Units)
Table 130. Asia-Pacific BGMS (Blood Glucose Monitoring System) Sales Quantity by Region (2018-2023) & (M Units)
Table 131. Asia-Pacific BGMS (Blood Glucose Monitoring System) Sales Quantity by Region (2024-2029) & (M Units)
Table 132. Asia-Pacific BGMS (Blood Glucose Monitoring System) Consumption Value by Region (2018-2023) & (USD Million)
Table 133. Asia-Pacific BGMS (Blood Glucose Monitoring System) Consumption Value by Region (2024-2029) & (USD Million)
Table 134. South America BGMS (Blood Glucose Monitoring System) Sales Quantity by Type (2018-2023) & (M Units)
Table 135. South America BGMS (Blood Glucose Monitoring System) Sales Quantity by Type (2024-2029) & (M Units)
Table 136. South America BGMS (Blood Glucose Monitoring System) Sales Quantity by Application (2018-2023) & (M Units)
Table 137. South America BGMS (Blood Glucose Monitoring System) Sales Quantity by Application (2024-2029) & (M Units)
Table 138. South America BGMS (Blood Glucose Monitoring System) Sales Quantity by Country (2018-2023) & (M Units)
Table 139. South America BGMS (Blood Glucose Monitoring System) Sales Quantity by Country (2024-2029) & (M Units)
Table 140. South America BGMS (Blood Glucose Monitoring System) Consumption Value by Country (2018-2023) & (USD Million)
Table 141. South America BGMS (Blood Glucose Monitoring System) Consumption Value by Country (2024-2029) & (USD Million)
Table 142. Middle East & Africa BGMS (Blood Glucose Monitoring System) Sales Quantity by Type (2018-2023) & (M Units)
Table 143. Middle East & Africa BGMS (Blood Glucose Monitoring System) Sales Quantity by Type (2024-2029) & (M Units)
Table 144. Middle East & Africa BGMS (Blood Glucose Monitoring System) Sales Quantity by Application (2018-2023) & (M Units)
Table 145. Middle East & Africa BGMS (Blood Glucose Monitoring System) Sales Quantity by Application (2024-2029) & (M Units)
Table 146. Middle East & Africa BGMS (Blood Glucose Monitoring System) Sales Quantity by Region (2018-2023) & (M Units)
Table 147. Middle East & Africa BGMS (Blood Glucose Monitoring System) Sales Quantity by Region (2024-2029) & (M Units)
Table 148. Middle East & Africa BGMS (Blood Glucose Monitoring System) Consumption Value by Region (2018-2023) & (USD Million)
Table 149. Middle East & Africa BGMS (Blood Glucose Monitoring System) Consumption Value by Region (2024-2029) & (USD Million)
Table 150. BGMS (Blood Glucose Monitoring System) Raw Material
Table 151. Key Manufacturers of BGMS (Blood Glucose Monitoring System) Raw Materials
Table 152. BGMS (Blood Glucose Monitoring System) Typical Distributors
Table 153. BGMS (Blood Glucose Monitoring System) Typical Customers
List of Figures
Figure 1. BGMS (Blood Glucose Monitoring System) Picture
Figure 2. Global BGMS (Blood Glucose Monitoring System) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global BGMS (Blood Glucose Monitoring System) Consumption Value Market Share by Type in 2022
Figure 4. Blood Glucose Test Strips Examples
Figure 5. Blood Glucose Meter Examples
Figure 6. Global BGMS (Blood Glucose Monitoring System) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global BGMS (Blood Glucose Monitoring System) Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Household Examples
Figure 10. Global BGMS (Blood Glucose Monitoring System) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global BGMS (Blood Glucose Monitoring System) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global BGMS (Blood Glucose Monitoring System) Sales Quantity (2018-2029) & (M Units)
Figure 13. Global BGMS (Blood Glucose Monitoring System) Average Price (2018-2029) & (USD/K Unit)
Figure 14. Global BGMS (Blood Glucose Monitoring System) Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global BGMS (Blood Glucose Monitoring System) Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of BGMS (Blood Glucose Monitoring System) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 BGMS (Blood Glucose Monitoring System) Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 BGMS (Blood Glucose Monitoring System) Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global BGMS (Blood Glucose Monitoring System) Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global BGMS (Blood Glucose Monitoring System) Consumption Value Market Share by Region (2018-2029)
Figure 21. North America BGMS (Blood Glucose Monitoring System) Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe BGMS (Blood Glucose Monitoring System) Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific BGMS (Blood Glucose Monitoring System) Consumption Value (2018-2029) & (USD Million)
Figure 24. South America BGMS (Blood Glucose Monitoring System) Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa BGMS (Blood Glucose Monitoring System) Consumption Value (2018-2029) & (USD Million)
Figure 26. Global BGMS (Blood Glucose Monitoring System) Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global BGMS (Blood Glucose Monitoring System) Consumption Value Market Share by Type (2018-2029)
Figure 28. Global BGMS (Blood Glucose Monitoring System) Average Price by Type (2018-2029) & (USD/K Unit)
Figure 29. Global BGMS (Blood Glucose Monitoring System) Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global BGMS (Blood Glucose Monitoring System) Consumption Value Market Share by Application (2018-2029)
Figure 31. Global BGMS (Blood Glucose Monitoring System) Average Price by Application (2018-2029) & (USD/K Unit)
Figure 32. North America BGMS (Blood Glucose Monitoring System) Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America BGMS (Blood Glucose Monitoring System) Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America BGMS (Blood Glucose Monitoring System) Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America BGMS (Blood Glucose Monitoring System) Consumption Value Market Share by Country (2018-2029)
Figure 36. United States BGMS (Blood Glucose Monitoring System) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada BGMS (Blood Glucose Monitoring System) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico BGMS (Blood Glucose Monitoring System) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe BGMS (Blood Glucose Monitoring System) Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe BGMS (Blood Glucose Monitoring System) Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe BGMS (Blood Glucose Monitoring System) Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe BGMS (Blood Glucose Monitoring System) Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany BGMS (Blood Glucose Monitoring System) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France BGMS (Blood Glucose Monitoring System) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom BGMS (Blood Glucose Monitoring System) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia BGMS (Blood Glucose Monitoring System) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy BGMS (Blood Glucose Monitoring System) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific BGMS (Blood Glucose Monitoring System) Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific BGMS (Blood Glucose Monitoring System) Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific BGMS (Blood Glucose Monitoring System) Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific BGMS (Blood Glucose Monitoring System) Consumption Value Market Share by Region (2018-2029)
Figure 52. China BGMS (Blood Glucose Monitoring System) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan BGMS (Blood Glucose Monitoring System) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea BGMS (Blood Glucose Monitoring System) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India BGMS (Blood Glucose Monitoring System) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia BGMS (Blood Glucose Monitoring System) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia BGMS (Blood Glucose Monitoring System) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America BGMS (Blood Glucose Monitoring System) Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America BGMS (Blood Glucose Monitoring System) Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America BGMS (Blood Glucose Monitoring System) Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America BGMS (Blood Glucose Monitoring System) Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil BGMS (Blood Glucose Monitoring System) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina BGMS (Blood Glucose Monitoring System) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa BGMS (Blood Glucose Monitoring System) Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa BGMS (Blood Glucose Monitoring System) Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa BGMS (Blood Glucose Monitoring System) Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa BGMS (Blood Glucose Monitoring System) Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey BGMS (Blood Glucose Monitoring System) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt BGMS (Blood Glucose Monitoring System) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia BGMS (Blood Glucose Monitoring System) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa BGMS (Blood Glucose Monitoring System) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. BGMS (Blood Glucose Monitoring System) Market Drivers
Figure 73. BGMS (Blood Glucose Monitoring System) Market Restraints
Figure 74. BGMS (Blood Glucose Monitoring System) Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of BGMS (Blood Glucose Monitoring System) in 2022
Figure 77. Manufacturing Process Analysis of BGMS (Blood Glucose Monitoring System)
Figure 78. BGMS (Blood Glucose Monitoring System) Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source